LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

Pre-treatment loss to follow-up among smear-positive pulmonary tuberculosis cases: a 10-year audit of national data from Fiji

Ram S, Kishore K, Batio I, Bissell K, Zachariah R, Satyanarayana S, Harries AD
Download
Download
Abstract
SETTING
All tuberculosis (TB) diagnostic and treatment centres in Fiji.

OBJECTIVES
To report on pre-treatment loss to follow-up rates over a 10-year period (2001-2010) and to examine if patients' age, sex and geographic origin are associated with the observed shortcomings in the health services.

METHODS
A retrospective review of routine programme data reconciling TB laboratory and treatment registers.

RESULTS
A total of 690 sputum smear-positive TB patients were diagnosed in the laboratory, of whom 579 (84%) were started on anti-tuberculosis treatment-an overall pre-treatment loss to follow-up of 111 (16%). Peak loss to follow-up rates were seen in 2003, 2004 and 2010. Pre-treatment losses were all aged ≥15 years. In the Western Division of Fiji, 33% of sputum-positive patients were declared pre-treatment loss to follow-up; this division had over five times the risk of such an adverse outcome compared to the Central Division (OR 5.2, 95%CI 3.1-8.9, P < 0.0001).

CONCLUSION
This study has identified an important shortcoming in programme linkage, communication and feedback between TB diagnostic and treatment services, leading to high pre-treatment loss to follow-up rates. This negatively influences TB services, and ways to rectify this situation are discussed.
Countries
Fiji
Subject Area
tuberculosisSORT-IT
DOI
10.5588/pha.12.0034
Published Date
21-Dec-2012
PubMed ID
26392972
Languages
English
Journal
Public Health Action
Volume / Issue / Pages
Volume 2, Issue 4, Pages 138-41
Issue Date
21-Dec-2012
Dimensions Badge